文献速递临床试验与 GCP真实世界研究与卫生经济

「Plants for Joints」多学科生活方式项目对类风湿关节炎、类风湿关节炎风险人群及代谢综合征相关骨关节炎患者的效果:随机对照试验方案

The effect of a multidisciplinary lifestyle program for patients with rheumatoid arthritis, an increased risk for rheumatoid arthritis or with metabolic syndrome-associated osteoarthritis: the "Plants for Joints" randomized controlled trial protocol.
PubMed 文献 · Trials · 2021-10-18

该方案设计了三项为期16周、观察者盲法、等待列表对照的随机对照试验,分别纳入低至中度疾病活动度的类风湿关节炎患者(n=80)、抗环瓜氨酸蛋白抗体阳性关节痛的风险人群(n=16)以及代谢综合征合并膝和/或髋骨关节炎患者(n=80)。干预基于全食物植物性饮食、运动与压力管理,主要结局分别为DAS28、RA风险评分和WOMAC评分的变化差异。

要点

  • 全食物植物性饮食联合运动与压力管理可能改善RA疾病活动度。
  • 该生活方式项目或降低ACPA阳性关节痛患者的RA发病风险评分。
  • 对代谢综合征相关骨关节炎,项目可能改善疼痛、僵硬与功能。

核心结论

  • 方案提出基于全食物植物性饮食、运动与压力管理的多学科生活方式项目,用于RA、RA风险人群及MSOA患者,并与常规照护比较。

研究设计与样本

  • 三项16周观察者盲法随机对照试验,设等待列表对照组。
  • RCT 1纳入低至中度疾病活动度RA患者(2.6≤DAS28≤5.1),n=80。
  • RCT 2纳入ACPA阳性关节痛的RA风险患者,n=16。
  • RCT 3纳入代谢综合征合并膝和/或髋OA患者,n=80。
  • 干预包括个人饮食与运动咨询后参加10次小组会议(每组6-12人),药物保持不变。

主要发现

  • 原文为方案论文,未报告主要结局结果。

关键数值与推荐

  • RCT 1主要结局为16周内DAS28平均变化在干预组与对照组间的差异。
  • RCT 2主要结局为16周内RA风险评分的组间平均变化差异。
  • RCT 3主要结局为16周内WOMAC评分的组间平均变化差异。

临床怎么用

  • 该方案为RA、RA风险人群及MSOA患者提供了一种多学科非药物生活方式干预的标准化实施框架。

局限性

  • 原文为方案论文,尚无疗效数据。
  • RCT 2样本量较小(n=16)。
  • 等待列表对照可能影响盲法实施与结果解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Low-grade inflammation and metabolic syndrome are seen in many chronic diseases, including rheumatoid arthritis (RA) and osteoarthritis (OA). Lifestyle interventions which combine different non-pharmacological therapies have shown synergizing effects in improving outcomes in patients with other chronic diseases or increased risk thereof, especially cardiovascular disease. For RA and metabolic syndrome-associated OA (MSOA), whole food plant-based diets (WFPDs) have shown promising results. A WFPD, however, had not yet been combined with other lifestyle interventions for RA and OA patients. In this protocol paper, we therefore present Plants for Joints, a multidisciplinary lifestyle program, based on a WFPD, exercise, and stress management. The objective is to study the effect of this program on disease activity in patients with RA (randomized controlled trial [RCT] 1), on a risk score for developing RA in patients with anti-citrullinated protein antibody (ACPA) positive arthralgia (RCT 2) and on pain, stiffness, and function in patients with MSOA (RCT 3), all in comparison with usual care.We designed three 16-week observer-blind RCTs with a waiting-list control group for patients with RA with low to moderate disease activity (2.6 ≤ Disease Activity Score [DAS28] ≤ 5.1, RCT 1, n = 80), for patients at risk for RA, defined by ACPA-positive arthralgia (RCT 2, n = 16) and for patients with metabolic syndrome and OA in the knee and/or hip (RCT 3, n = 80). After personal counseling on diet and exercise, participants join 10 group meetings with 6-12 other patients to receive theoretical and practical training on a WFPD, exercise, and stress management, while medication remains unchanged. The waiting-list control group receives usual care, while entering the program after the RCT. Primary outcomes are: difference in mean change between intervention and control groups within 16 weeks for the DAS28 in RA patients (RCT 1), the RA-risk score for ACPA positive arthralgia patients (RCT 2), and the Western Ontario and McMaster Universities Arthritis Index (WOMAC) score for MSOA patients (RCT 3). Continued adherence to the lifestyle program is measured in a two-year observational extension study.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Walrabenstein W, van der Leeden M, Weijs P, et al. The effect of a multidisciplinary lifestyle program for patients with rheumatoid arthritis, an increased risk for rheumatoid arthritis or with metabolic syndrome-associated osteoarthritis: the "Plants for Joints" randomized controlled trial protocol. Trials. 2021. PMID: 34663431. doi:10.1186/s13063-021-05682-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。